The Aptima STI testing portfolio addresses a global need to detect and prevent the spread of sexually transmitted infections (STIs, also known as sexually transmitted diseases or STDs). Our diverse STI testing menu allows lab personnel to deliver results to healthcare providers with confidence, empowering informed choices when it comes to patient care. At Hologic, we focus on improving testing and technology to enable healthier lives everywhere, every day.
Our molecular diagnostic offerings allow healthcare providers to collect one patient specimen that yields multiple test results on the fully automated Panther® system.
Aptima STI assays bring The Science of Sure® to life. Our nucleic acid amplification tests (NAATs) target common STIs such as chlamydia, gonorrhea, Mycoplasma genitalium, trichomoniasis, herpes and emerging pathogens like the Zika virus. Hologic is committed to protecting the reproductive health of women and men through early detection of STIs.